Home / Late annual reports / TherapeuticsMD, Inc.
Filed 2026-04-01 路 Form NT 10-K 路 Accession 0001213900-26-037914 nano
Price before filing: $2.02 (2026-03-31 close, split/dividend-adjusted)
Market cap at flag: $23.1M (2026-04-01) 路 Latest: $22.0M (2026-10-16)
| Window | TXMD | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +2.5% | +10.8% | -8.3% | 2026-05-01 |
| 90 days | +9.4% | +15.1% | -5.7% | 2026-06-30 |
| 180 days | +3.5% | +18.3% | -14.9% | 2026-09-28 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-01-01 to 2026-05-01. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
The company told the SEC it could not file its annual report on time (Form NT 10-K) and then missed the 15-day extension too. Late annual reports often precede restatements, auditor problems or going-concern warnings.
Status: still missing
Why this score: report still not filed after extension; also within 90 days: Auditor change, Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.